Brief: Neurovive Receives Kl1333 Clinical Trial Regulatory Approval

Abliva AB

10/10/2018 07:34

NeuroVive Pharmaceutical AB  NVP.ST :
    * NEUROVIVE RECEIVES KL1333 CLINICAL TRIAL REGULATORY
APPROVAL

Source text for Eikon:  ID:nWkr4yFGxH 
Further company coverage:  NVP.ST